Filing Details

Accession Number:
0001181431-12-010327
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-21 14:46:07
Reporting Period:
2012-02-17
Filing Date:
2012-02-21
Accepted Time:
2012-02-21 14:46:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235612 Laurie Brlas C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-17 4,650 $23.44 21,963 No 4 M Direct
Common Stock Disposition 2012-02-17 4,650 $94.78 17,313 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option Right to Buy Disposition 2012-02-17 4,650 $0.00 4,650 $23.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-11-04 2017-10-30 No 4 M Direct
Footnotes
  1. The price in column 4 is a weighted average. The prices actually received ranged from $94.38 to $95.08. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.